Physical Activity Level and Hormonal Status on Energy Metabolism and Nutritional Responses
NCT ID: NCT05944653
Last Updated: 2023-07-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
48 participants
OBSERVATIONAL
2023-07-31
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is indeed recognized that the level of physical activity and sedentary behaviours influence the energy expenditure of rest and exercise and also the control of appetite; the investigators have recently shown that this level of physical activity modifies the cardiometabolic responses following a meal in healthy men. This underlines the importance of considering inter-individual parameters, such as the level of physical activity and sedentary lifestyle as a predominant factor in nutritional and energy regulation at rest and during physical exercise, a key factor in energy regulation. In general, studies in women concerning the parameters of the energy balance are heterogeneous in terms of the characteristics of the population, the methodology used and do not take into account all the metabolic and nutritional responses that make it possible to understand these regulations.
Thus, the main objective of this study is to evaluate the effects of hormonal status (women with and without hormonal contraception) on the fuel utilization during low-intensity physical exercise in women of childbearing age according to their level of physical activity.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Association Between the Menstrual Cycle and Weight Loss in Healthy, Overweight Premenopausal Women
NCT01622114
Aging, Exercise, and Hormonal Influences of Fat Metabolism
NCT00100451
Evaluation of Lifestyle Modification on Cardiovascular Risk
NCT05417698
Anthropometric, Metabolic, Cardiovascular and Symptomatic Profile in Postmenopausal Women
NCT01745042
Effect of Weight Loss on Cardiovascular Disease Risk Factors in Obese Women
NCT01353001
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women with hormonal contraception
No interventions assigned to this group
Women without hormonal contraception
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI between 18 and 25 kg.m-2
* Subject able to provide informed consent to participate
* Subject with a Social Security
Exclusion Criteria
* Presence of comorbidities or pathology that could interfere with the study data
* Women in the process of food restriction or weight loss at the time of inclusion or during the last three months
* Irregular menstrual cycles
* Menstrual cycles \< 25 days or greater than 35 days
* Pregnant or lactating women
* Per or post menopausal women
* Claustrophobia
* Person in period of exclusion from another study
* Person under guardianship or safeguard of justice; or subject without social security
18 Years
44 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martine DUCLOS
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Clermont-Ferrand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU clermont-ferrand
Clermont-Ferrand, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A00685-40
Identifier Type: OTHER
Identifier Source: secondary_id
RBHP 2023 DUCLOS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.